Symon Kariuki/Wellcome Open Res

A Phase I trial of Non-invasive Ventilation and seizure prophylaxis with levetiracetam In Children with Cerebral Malaria Trial (NOVICE-M Trial).Maitland, K. Obonyo, N. Hamaluba, M. Ogoda, E. Mogaka, C. Williams, T. N. Newton, C. Kariuki, S. M. Gibb, D. M. Walker, A. S. Connon, R. George, E. C.
Wellcome Open Res, (2024). 9:281

Therapeutic monitoring of anti-seizure medications in low- and middle-income countries: a systematic review.Odhiambo, M. Kariuki, S. M. Newton, C. R.
Wellcome Open Res, (2024). 6:92

Barriers to access and utilization of healthcare by children with neurological impairments and disability in low-and middle-income countries: a systematic review.Mwangi, L. W. Abuga, J. A. Cottrell, E. Kariuki, S. M. Kinyanjui, S. M. Newton, C. R.
Wellcome Open Res, (2022). 6:61

Validity and reliability of the Neurodevelopmental Screening Tool (NDST) in screening for neurodevelopmental disorders in children living in rural Kenyan coast.Bitta, M. A. Kipkemoi, P. Kariuki, S. M. Abubakar, A. Gona, J. Philips-Owen, J. Newton, C. R.
Wellcome Open Res, (2021). 6:137

Burden of neurodevelopmental disorders in low and middle-income countries: A systematic review and meta-analysis.Bitta, M. Kariuki, S. M. Abubakar, A. Newton, C. R. J. C.
Wellcome Open Res, (2017). 2:121

Cerebrospinal fluid markers to distinguish bacterial meningitis from cerebral malaria in children.Njunge, J. M. Oyaro, I. N. Kibinge, N. K. Rono, M. K. Kariuki, S. M. Newton, C. R. Berkley, J. A. Gitau, E. N.
Wellcome Open Res, (2017). 2:47

Antimalarial drugs and the prevalence of mental and neurological manifestations: A systematic review and meta-analysis.Bitta, M. A. Kariuki, S. M. Mwita, C. Gwer, S. Mwai, L. Newton, C. R. J. C.
Wellcome Open Res, (2017). 2:13